Microvessel density in prostate cancer: lack of correlation with tumor grade, pathologic stage, and clinical outcome.
about
Molecular biology of breast cancer metastasis. Molecular expression of vascular markers by aggressive breast cancer cells.Nestin: a novel angiogenesis marker and possible target for tumor angiogenesisReconsideration of the clinical and histopathological significance of angiogenesis in prostate cancer: Usefulness and limitations of microvessel density measurementVasculogenic mimicry and tumor angiogenesis.Fast dynamic gadolinium-enhanced MR imaging of urinary bladder and prostate cancer.The role of angiogenesis in prostate and other urologic cancers: a review.The Way that PEGyl-DSPC Liposomal Doxorubicin Particles Penetrate into Solid Tumor Tissue.Contrast enhanced computed tomography is indicative for angiogenesis pattern and display prognostic significance in breast cancer.The use of microvessel density in assessing human urological tumours.Prognostic factors in prostate cancer.Expression and clinical significance of microvessel density and its association with TWIST in nasopharyngeal carcinomaAssociation between tumor-associated macrophages and microvessel density on prostate cancer progression.Prognostic factors and reporting of prostate carcinoma in radical prostatectomy and pelvic lymphadenectomy specimens.The role of magnetic resonance imaging (MRI) in prostate cancer imaging and staging at 1.5 and 3 Tesla: the Beth Israel Deaconess Medical Center (BIDMC) approachProspective study of prostate tumor angiogenesis and cancer-specific mortality in the health professionals follow-up study.Dynamic contrast-enhanced magnetic resonance imaging and pharmacokinetic models in prostate cancer.MRI of the prostate: clinical relevance and emerging applications.Angiogenesis in prostate cancer: onset, progression and imaging.The role of treatment modality on the utility of predictive tissue biomarkers in clinical prostate cancer: a systematic review.Prolactin- and testosterone-induced carboxypeptidase-D correlates with increased nitrotyrosines and Ki67 in prostate cancer.Dynamic contrast-enhanced MRI for oncology drug development.Tumor angiogenesis as an early marker of long-term prostate cancer mortality.Adenoviral vectors expressing human endostatin-angiostatin and soluble Tie2: enhanced suppression of tumor growth and antiangiogenic effects in a prostate tumor model.The prognostic significance of vasohibin-1 expression in patients with prostate cancerLong-term assessment of prostate cancer progression free survival: evaluation of pathological parameters, nuclear shape and molecular biomarkers of pathogenesis.Angiogenesis and host immune response contribute to the aggressive character of non-melanoma skin cancers in renal transplant recipients.Is angiogenesis a hallmark of prostate cancer?Prognostic value of microvessel density in prostate cancer: a tissue microarray study.Differential expression of VEGF ligands and receptors in prostate cancer.Elements regulating angiogenesis and correlative microvessel density in benign hyperplastic and malignant prostate tissue.Whole-mount prostate sections reveal differential endoglin expression in stromal, epithelial, and endothelial cells with the development of prostate cancer.Increased lymphatic vessel density and lymphangiogenesis in inflammatory bowel disease.The Value of Contrast-Enhanced Ultrasonography Combined with Real-Time Strain Elastography in the Early Diagnosis of Prostate Cancer.Vascular proliferation is a prognostic factor in breast cancer
P2860
Q24800983-0CA75124-2B39-44EF-9AE0-54BF4DE27448Q26824035-4E6F9E62-3131-4D9F-A703-C93CDC8D4183Q28084794-B36F5E1F-D9C5-42F1-A14B-9F70D324346EQ30498765-8D1CEBEB-6FDD-4817-A95B-53EA31B1E5F1Q33744680-AFA4D7AC-E1C4-455D-A0BF-5DDC449E6406Q33955367-1562E557-D138-49B3-8C86-5B002B5406A4Q34013560-47C706D7-81F1-4E91-81CA-9F714BE1886BQ34250656-AA233B20-BE8E-476E-A6A0-DE45BD87F7EDQ34285922-7B75B6D0-A16B-4957-805D-E49854C5D98FQ34682069-D69324D5-2220-4DCD-BA7B-22BBD2AD999AQ35173844-D62134E8-3347-4267-9B08-1A60A6EB5546Q35809905-06022DBF-A270-4B61-B8FF-F58889C9B669Q36194959-F49EECF2-BF9E-4C5A-8D16-150D4DD2119DQ37337735-6F9B05C3-A391-4C49-949B-45096183C307Q37474075-BE5C3E7D-170E-4CEF-B720-37156C365E50Q37823843-A4EA804D-763A-4285-9101-DB3C49797FA8Q37833011-2DBDBECF-A3A3-44D6-9F8A-5716A3F43A93Q38041673-92EB2791-1F31-4834-9713-807461EA20E6Q38063121-B351F647-8E4F-40AF-BAED-456113DAC7BDQ38385340-CDA0722D-BD97-46B0-B6DA-C1E4B642B56BQ38725827-4E83254C-7890-4865-8AA7-2CD12550B650Q39892850-0B184907-2B37-4593-AEF3-D07B0D96B517Q40372092-C6050F22-6B8C-484B-8A91-40399690BD93Q41418421-00E3F1B4-372B-495E-98B1-E28B1351E1FCQ42120683-FBC1683C-E54D-49F3-AB2B-186BB6A7A700Q42488475-2E7C7ADA-0946-47F2-BE5A-4DFCF41CEC73Q43180094-442FD976-CC37-472C-9788-20DB0F9C521CQ43542884-9461DB4B-7F5F-4C5A-AE6B-D4236FB6F3F6Q46122468-D571686A-BD0B-48B2-ABE3-454E4B9D7B95Q46306064-E4094E47-ED8D-420D-A3F8-56911A9241DCQ47399778-D2411538-7803-4D25-BC2A-B0FC830982DFQ54360844-41803FA4-A1DB-449E-944C-51CB2AE394D5Q55010851-52E0BB08-7E54-4D43-A6F4-B0A9ED889FFAQ59238285-2438E210-CFB1-4CD8-87D4-BA921B553DE5
P2860
Microvessel density in prostate cancer: lack of correlation with tumor grade, pathologic stage, and clinical outcome.
description
1999 nî lūn-bûn
@nan
1999 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մարտին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Microvessel density in prostat ...... c stage, and clinical outcome.
@ast
Microvessel density in prostat ...... c stage, and clinical outcome.
@en
Microvessel density in prostat ...... c stage, and clinical outcome.
@nl
type
label
Microvessel density in prostat ...... c stage, and clinical outcome.
@ast
Microvessel density in prostat ...... c stage, and clinical outcome.
@en
Microvessel density in prostat ...... c stage, and clinical outcome.
@nl
prefLabel
Microvessel density in prostat ...... c stage, and clinical outcome.
@ast
Microvessel density in prostat ...... c stage, and clinical outcome.
@en
Microvessel density in prostat ...... c stage, and clinical outcome.
@nl
P2093
P1433
P1476
Microvessel density in prostat ...... c stage, and clinical outcome.
@en
P2093
Bagiella E
Buyyounouski M
de la Taille A
P304
P356
10.1016/S0090-4295(98)00561-5
P407
P577
1999-03-01T00:00:00Z